Sera Prognostics (SERA) FCF Margin (2020 - 2026)
Sera Prognostics (SERA) reported FCF Margin of 62728.57% for Q1 2026, down 4284436.0% on a YoY basis from N/an in Q1 2025, and up 2.75% quarter-over-quarter from 64500.0% in Q4 2025.
Sera Prognostics (SERA) FCF Margin (2020 - 2026) Analysis & Trends
Sera Prognostics has reported FCF Margin for 7 years, with the latest figure at 62728.57% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin fell 4284436.0% year-over-year to 62728.57%; the trailing twelve-month figure through Mar 2026 stood at 48377.19% (down 2509024.0% YoY), and the FY2025 full-year result was 32529.63%, down 1402963.0% from the prior year.
- FCF Margin for Q1 2026 stood at 62728.57%, up from 64500.0% in the prior quarter.
- The five-year high for FCF Margin was 4920.0% in Q1 2023, with the low at 64500.0% in Q4 2025.
- Historically, FCF Margin has averaged 25142.74% across 5 years, with a median of 22047.28% in 2024.
- Annual changes were most pronounced in 2022 — FCF Margin jumped 3176652 bps — and 2026, when it plunged 4284436 bps.
- Sera Prognostics' FCF Margin stood at 11432.31% in 2022, then tumbled by 45 bps to 16539.02% in 2023, then slumped by 58 bps to 26116.67% in 2024, then plunged by 147 bps to 64500.0% in 2025, then grew by 3 bps to 62728.57% in 2026.
- The last three FCF Margin figures came in at 62728.57% (Q1 2026), 64500.0% (Q4 2025), and 41181.25% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 25.51% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -1.28% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 3.98% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.68% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 37.67% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 15.44% |
| 10 | Sera Prognostics | 100.52 Mn | 100.52 Mn | -28,000.00 | -62,728.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -62,728.57% |
| Dec 31, 2025 | -64,500.00% |
| Sep 30, 2025 | -41,181.25% |
| Jun 30, 2025 | -33,847.06% |
| Mar 31, 2025 | -19,884.21% |
| Dec 31, 2024 | -26,116.67% |
| Sep 30, 2024 | -24,210.34% |
| Jun 30, 2024 | -24,729.17% |
| Dec 31, 2023 | -16,539.02% |
| Sep 30, 2023 | -18,142.86% |
| Jun 30, 2023 | -6,500.00% |
| Mar 31, 2023 | -4,920.00% |
| Dec 31, 2022 | -11,432.31% |
| Sep 30, 2022 | -10,516.09% |
| Jun 30, 2022 | -11,867.95% |
| Mar 31, 2022 | -25,168.42% |
| Dec 31, 2021 | -38,080.77% |
| Sep 30, 2021 | -42,282.61% |
| Jun 30, 2021 | -31,615.00% |
| Mar 31, 2021 | -53,776.92% |